Inicio › Nefritis lúpica › Nueva York
Ensayos clínicos de Nefritis lúpica en Nueva York
15 estudios sobre Nefritis lúpica buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Circuit Clinical, Orchard Park
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 9 nov 2026 · NCT06711887A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cohen Children's Medical Center of New York, Queens
ReclutandoFase 2
Edades de 5 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05039619A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07085104Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
ReclutandoFase 2
Edades de 12 a 65 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07053800RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
ReclutandoFase 1/2
Edades de 12 a 65 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06121297A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
ReclutandoFase 2
Edades de 16 a 70 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07328581VIBRANT: VIB4920 for Active Lupus Nephritis
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Hospital for Special Surgery, New York
- Children's Hospital at Montefiore, New York
ReclutandoFase 2
Edades de 8 a 20 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05538208A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 10 sept 2026 · NCT06897930PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Buffalo Rheumatology and Medicine, PLLC, Orchard Park
ReclutandoFase 4
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 ago 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
ReclutandoFase 1
Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- y 1 más
ReclutandoEstudio observacional
Edades de 18 a 110 · Todos los sexos · Actualizado el 15 abr 2026 · NCT05934149Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 nov 2025 · NCT07107659Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 abr 2025 · NCT01802034De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.